Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decisio...
Manufactured by
Clinomics Europe Kft.
Budapest, Hungary
Clinomics Europe was founded in Budapest in 2021 as an innovative medical biotechnology company specializing in multiomics-based precision medicine and oncology . We develop and deploy next-generation molecular diagnostic tools using cutting-edge technologies, including liquid biopsy, next-generation sequencing (NGS), real-time qPCR, and digital PCR (dPCR) . Minimally invasive and repeatable methods, such as liquid biopsy, offer major advantages over traditional gold-standard techniques in oncology. They enable early diagnosis, real-time monitoring, and longitudinal assessment of therapy effectiveness. Blood-based biomarkers, including circulating tumor cells (CTCs) and cell-free DNA and RNA, are emerging as more sensitive and specific alternatives to traditional biomarkers. By integrating liquid biopsy with advanced molecular technologies such as NGS, qPCR, and dPCR , we aim to revolutionize cancer detection and patient treatment outcomes globally.
© 2026 Suplivia · Home · Browse Products